![](/img/cover-not-exists.png)
Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia
Ishizawa, Kenichi, Fukuhara, Noriko, Nakaseko, Chiaki, Chiba, Shigeru, Ogura, Michinori, Okamoto, Akihiko, Sunaga, Yoshinori, Tobinai, KenseiVolume:
47
Language:
english
Journal:
Japanese Journal of Clinical Oncology
DOI:
10.1093/jjco/hyw146
Date:
January, 2017
File:
PDF, 166 KB
english, 2017